Modern Science Daily is a blog Powered By G-Plans, Goglia Nutrition LLC

*Results vary based on starting weight and program adherence. Inches lost from hips, waist, chest, thighs and arms in the first month.

These users exercised daily and ate a reduced-calorie diet. Their fat loss is not typical.

Results from RX Path may vary. Medication prescriptions are at the discretion of medical providers and may not be suitable for everyone. G-Plans typically result in 1-2 lbs per week weight loss in 4 weeks, involving a healthy diet and exercise changes. Consult a healthcare professional before using RX Path or starting any weight loss program.

*Based on the average weight loss in three 68-week clinical trials of patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity. See details.

Medication is not included in the cost of the G-Plans Program. But don’t worry, our insurance concierge partners explore all options to help get you covered.

Wegovy® is FDA-approved for weight loss. Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss.

The trademarks, service marks, trade names (Wegovy® ,Ozempic®), and products displayed on this Internet site are protected and belong to their respetive owners.

Medical treatment is provided by “G-Plans Affiliated P.C.s,” an affiliated network for medical professional corporations and associations.